Save time and get answers to complex questions with AI chat
Dabrafenib patent expiration date novartis gsk composition matter?When is tenofovir alafenamide patent expiring?Is allopurinol expensive?Stribild expiry date?Drug patent watch trametinib?
See the DrugPatentWatch profile for Toujeo
Toujeo is a trademark owned by Sanofi (Sanofi S.A.). In the U.S. the mark is held by Sanofi US LLC (a Sanofi subsidiary). Toujeo is Sanofi’s insulin glargine U-300 product. If you need the exact current owner in a specific country, you can check the local trademark registry (USPTO, EUIPO, etc.) or the WIPO Global Brand Database.
Other Questions About Toujeo :